<?xml version="1.0" encoding="UTF-8" ?>

<Genomics_ConceptTask>
<TEXT><![CDATA[Stromal SNAI2 Is Required for ERBB2 Breast Cancer Progression.

SNAI2 overexpression appears to be associated with poor prognosis in breast 
cancer, yet it remains unclear in which breast cancer subtypes this occurs. Here 
we show that excess SNAI2 is associated with a poor prognosis of luminal B 
HER2+/ERBB2+ breast cancers in which SNAI2 expression in the stroma but not the 
epithelium correlates with tumor proliferation. To determine how stromal SNAI2 
might influence HER2+ tumor behavior, Snai2-deficient mice were crossed with a 
mouse line carrying the ErbB2/Neu protooncogene to generate HER2+/ERBB2+ breast 
cancer. Tumors generated in this model expressed SNAI2 in the stroma but not the 
epithelium, allowing for the role of stromal SNAI2 to be studied without 
interference from the epithelial compartment. The absence of SNAI2 in the stroma 
of HER2+/ERBB2+ tumors is associated with: (i) lower levels of cyclin D1 (CCND1) 
and reduced tumor epithelium proliferation; (ii) higher levels of AKT and a 
lower incidence of metastasis; (iii) lower levels of angiopoietin-2 (ANGPT2), 
and more necrosis. Together, these results indicate that the loss of SNAI2 in 
cancer-associated fibroblasts limits the production of some cytokines, which 
influences AKT/ERK tumor signaling and subsequent proliferative and metastatic 
capacity of ERBB2+ breast cancer cells. Accordingly, SNAI2 expression in the 
stroma enhanced the tumorigenicity of luminal B HER2+/ERBB2+ breast cancers. 
This work emphasizes the importance of stromal SNAI2 in breast cancer 
progression and patients' prognosis. ]]></TEXT>
<TAGS>
<PERTURBING_ACTION id="P0" spans="498~513" text="Snai2-deficient" description="knock out" />
<PERTURBING_ACTION id="P1" spans="551~587" text="carrying the ErbB2/Neu protooncogene" description="other" />
<PERTURBING_ACTION id="P3" spans="827~857" text="absence of SNAI2 in the stroma" description="conditional knock out" />
<PERTURBING_ACTION id="P5" spans="1387~1418" text="SNAI2 expression in the  stroma" description="increased expression level" />
<PERTURBING_ACTION id="P6" spans="1158~1205" text="loss of SNAI2 in  cancer-associated fibroblasts" description="conditional knock out" />
<CONTEXT id="C0" spans="514~518" text="mice" experiment_type="organism" species="mouse" />
<CONTEXT id="C1" spans="540~550" text="mouse line" experiment_type="organism" species="mouse" />
<CONTEXT id="C2" spans="862~881" text="HER2+/ERBB2+ tumors" experiment_type="tumour" species="not stated" />
<CONTEXT id="C3" spans="953~969" text="tumor epithelium" experiment_type="tumour" species="not stated" />
<CONTEXT id="C5" spans="1346~1372" text="ERBB2+ breast cancer cells" experiment_type="transformed cell line" species="not stated" />
<CONTEXT id="C6" spans="1450~1487" text="luminal B HER2+/ERBB2+ breast cancers" experiment_type="tumour" species="not stated" />
<EFFECT id="E1" spans="600~627" text="HER2+/ERBB2+ breast  cancer" phenotype="tumourigenesis" activity="causes" />
<EFFECT id="E2" spans="945~952,970~983" text="reduced ... proliferation" phenotype="proliferation" activity="decreases" />
<EFFECT id="E4" spans="1018~1047" text="lower incidence of metastasis" phenotype="metastasis" activity="decreases" />
<EFFECT id="E5" spans="1101~1114" text="more necrosis" phenotype="necrosis" activity="increases" />
<EFFECT id="E6" spans="1254~1264,1304~1317,1334~1342" text="influences ... proliferative ... capacity" phenotype="proliferation" activity="regulates" />
<EFFECT id="E7" spans="1254~1264,1322~1342" text="influences ... metastatic  capacity" phenotype="metastasis" activity="regulates" />
<EFFECT id="E8" spans="1419~1446" text="enhanced the tumorigenicity" phenotype="tumourigenesis" activity="increases" />
<ENTITY_LINKING id="EN0" perturbing_actionID="P3" perturbing_actionText="absence of SNAI2 in the stroma" effectID="E2" effectText="reduced ... proliferation" contextID="C3" contextText="tumor epithelium" />
<ENTITY_LINKING id="EN1" perturbing_actionID="P3" perturbing_actionText="absence of SNAI2 in the stroma" contextID="C2" contextText="HER2+/ERBB2+ tumors" effectID="E4" effectText="lower incidence of metastasis" />
<ENTITY_LINKING id="EN2" perturbing_actionID="P3" perturbing_actionText="absence of SNAI2 in the stroma" contextID="C2" contextText="HER2+/ERBB2+ tumors" effectID="E5" effectText="more necrosis" />
<ENTITY_LINKING id="EN3" perturbing_actionID="P6" perturbing_actionText="loss of SNAI2 in  cancer-associated fibroblasts" contextID="C5" contextText="ERBB2+ breast cancer cells" effectID="E6" effectText="influences ... proliferative ... capacity" />
<ENTITY_LINKING id="EN4" perturbing_actionID="P6" perturbing_actionText="loss of SNAI2 in  cancer-associated fibroblasts" contextID="C5" contextText="ERBB2+ breast cancer cells" effectID="E7" effectText="influences ... metastatic  capacity" />
<ENTITY_LINKING id="EN5" perturbing_actionID="P5" perturbing_actionText="SNAI2 expression in the  stroma" effectID="E8" effectText="enhanced the tumorigenicity" contextID="C6" contextText="luminal B HER2+/ERBB2+ breast cancers" />
</TAGS>
</Genomics_ConceptTask>